Skip to main content

Table 1 Correlation between UCHL1 expression and clinicopathological characteristics of 483 patients with lung adenocarcinoma from TCGA database

From: UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma

Factors

Number of cases (n)

UCHL1 expression

c2

P

Low (n = 241)

High (n = 242)

Sex

   

6.785

0.009*

 Male

223

97

126

  

 Female

260

144

116

  

Age (years)

   

1.697

0.193

 < 60

131

59

72

  

 ≥ 60

352

182

170

  

T

   

0

1

 T1–2

418

209

209

  

 T3–4

62

31

31

  

 Tx

3

    

N

   

1.361

0.243

 N0

312

163

149

  

 N1–3

161

75

86

  

 Nx

10

    

M

   

2.465

0.116

 M0

319

154

165

  

 M1

25

8

17

  

 Mx

139

    

Stage

   

0.278

0.598

 I–II

378

191

187

  

 III–IV

105

50

55

  
  1. Analyses were performed using the c2 test
  2. Tx the primary tumor cannot be determined, Nx unable to evaluate, Mx unable to evaluate
  3. *P < 0.05
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us